[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 2512 Introduced in Senate (IS)]

<DOC>






114th CONGRESS
  2d Session
                                S. 2512

To expand the tropical disease product priority review voucher program 
                to encourage treatments for Zika virus.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            February 8, 2016

   Mr. Franken (for himself, Mr. Nelson, Mr. Isakson, and Mr. Brown) 
introduced the following bill; which was read twice and referred to the 
          Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
To expand the tropical disease product priority review voucher program 
                to encourage treatments for Zika virus.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Adding Zika Virus to the FDA 
Priority Review Voucher Program Act''.

SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER 
              PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA VIRUS.

    Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360n) is amended--
            (1) by redesignating subparagraph (R) as subparagraph (S); 
        and
            (2) by inserting after subparagraph (Q) the following:
                    ``(R) Zika virus.''.
                                 <all>
